-
IMV Inc. NASDAQ:IMV
Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
2.66%
Insider Ownership
0.41%
Institutional Own.
20.37%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Maveropepimut-S (DPX-Survivac) (Survivin) + CPA Details Ovarian cancer, Cancer | Phase 2b Update | |
Maveropepimut-S (DPX-Survivac) (Survivin) + Keytruda + CPA Details Diffuse large B cell lymphoma, Cancer | Phase 2b Update | |
Maveropepimut-S (DPX-Survivac) (Survivin) + CPA + Pemrolizumab Details Cancer, Ovarian cancer | Phase 2 Update | |
Maveropepimut-S (DPX-Survivac) (Survivin) Details Cancer, Solid tumor/s, Breast cancer | Phase 1b Update | |
DPX-RSV Details Respiratory syncytial virus | Failed Discontinued | |
Maveropepimut-S (DPX-Survivac) (Survivin) + CPA + Keytruda Details Ovarian cancer, Bladder cancer, Liver cancer, Cancer | Failed Discontinued | |
DPX-COVID-19 Details COVID-19 | Failed Discontinued |